Genetic Profile and Symptom Pattern Explain Variability of Deep Brain Stimulation Effect in Dystonia

ABSTRACT Objective Bilateral globus pallidus pars interna deep brain stimulation (GPi‐DBS) is a recognized and effective treatment option for drug‐resistant dystonia patients. However, the clinical GPi‐DBS outcomes vary significantly. Herein, we explored the pre‐implant factors affecting GPi‐DBS eff...

Full description

Saved in:
Bibliographic Details
Main Authors: Mahboubeh Ahmadipour, Luigi M. Romito, Antonio E. Elia, Nico Golfré Andreasi, Roberto Eleopra, Alberto Mazzoni, Fabiana Colucci
Format: Article
Language:English
Published: Wiley 2025-08-01
Series:Annals of Clinical and Translational Neurology
Subjects:
Online Access:https://doi.org/10.1002/acn3.70098
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849404835717185536
author Mahboubeh Ahmadipour
Luigi M. Romito
Antonio E. Elia
Nico Golfré Andreasi
Roberto Eleopra
Alberto Mazzoni
Fabiana Colucci
author_facet Mahboubeh Ahmadipour
Luigi M. Romito
Antonio E. Elia
Nico Golfré Andreasi
Roberto Eleopra
Alberto Mazzoni
Fabiana Colucci
author_sort Mahboubeh Ahmadipour
collection DOAJ
description ABSTRACT Objective Bilateral globus pallidus pars interna deep brain stimulation (GPi‐DBS) is a recognized and effective treatment option for drug‐resistant dystonia patients. However, the clinical GPi‐DBS outcomes vary significantly. Herein, we explored the pre‐implant factors affecting GPi‐DBS effectiveness. Methods Genetic profiles, symptom distribution, age at onset, disease duration, and severity of a cohort of 31 GPi‐DBS dystonia patients were collected. Dystonia motor severity was evaluated before and after GPi‐DBS using the Burke–Fahn–Marsden Dystonia‐Rating‐Scale (BFMDRS‐M). We assessed the interplay of the aforementioned factors in determining the BFMDRS‐M improvement through a multilinear regression analysis. Results BFMDRS‐M score showed a significant improvement (47.8%) since the first year, remaining stable at 5 years (54.3%). Lower limb (0.20), upper limb (0.16) and trunk (0.24) symptoms showed a significantly larger improvement compared to cranial symptoms (0.07, p < 0.05). Consequently, patients with more pronounced lower limb motor symptoms displayed a greater GPi‐DBS effect (p < 0.01). However, pre‐treatment localization of motor symptoms accounted only for 31% of the Inter‐Patient Variability (IPV) in post‐GPi‐DBS improvement. Amelioration varied also across genetic profiles, with the largest improvement reported for DYT‐TOR1A patients (n = 9, 64.2% in the first year), predicting 36% of IPV. Interestingly, combining motor and genetic profiles predicted 73% of the IPV. Including the clinical profile of the patient (age at onset, disease severity and duration) increased prediction accuracy to 81%. Interpretation Our results suggest that motor and genetic profiles contribute independently to the efficacy of the GPi‐DBS treatment. These results may support a personalized prediction of DBS outcomes in dystonia patients.
format Article
id doaj-art-4170af393fcb49dc8064c37fc154d4a5
institution Kabale University
issn 2328-9503
language English
publishDate 2025-08-01
publisher Wiley
record_format Article
series Annals of Clinical and Translational Neurology
spelling doaj-art-4170af393fcb49dc8064c37fc154d4a52025-08-20T03:36:49ZengWileyAnnals of Clinical and Translational Neurology2328-95032025-08-011281660166910.1002/acn3.70098Genetic Profile and Symptom Pattern Explain Variability of Deep Brain Stimulation Effect in DystoniaMahboubeh Ahmadipour0Luigi M. Romito1Antonio E. Elia2Nico Golfré Andreasi3Roberto Eleopra4Alberto Mazzoni5Fabiana Colucci6The Biorobotics Institute Scuola Superiore Sant'Anna Pisa ItalyMovement Disorders Department Fondazione IRCCS Istituto Neurologico Carlo Besta Milan ItalyMovement Disorders Department Fondazione IRCCS Istituto Neurologico Carlo Besta Milan ItalyMovement Disorders Department Fondazione IRCCS Istituto Neurologico Carlo Besta Milan ItalyMovement Disorders Department Fondazione IRCCS Istituto Neurologico Carlo Besta Milan ItalyThe Biorobotics Institute Scuola Superiore Sant'Anna Pisa ItalyMovement Disorders Department Fondazione IRCCS Istituto Neurologico Carlo Besta Milan ItalyABSTRACT Objective Bilateral globus pallidus pars interna deep brain stimulation (GPi‐DBS) is a recognized and effective treatment option for drug‐resistant dystonia patients. However, the clinical GPi‐DBS outcomes vary significantly. Herein, we explored the pre‐implant factors affecting GPi‐DBS effectiveness. Methods Genetic profiles, symptom distribution, age at onset, disease duration, and severity of a cohort of 31 GPi‐DBS dystonia patients were collected. Dystonia motor severity was evaluated before and after GPi‐DBS using the Burke–Fahn–Marsden Dystonia‐Rating‐Scale (BFMDRS‐M). We assessed the interplay of the aforementioned factors in determining the BFMDRS‐M improvement through a multilinear regression analysis. Results BFMDRS‐M score showed a significant improvement (47.8%) since the first year, remaining stable at 5 years (54.3%). Lower limb (0.20), upper limb (0.16) and trunk (0.24) symptoms showed a significantly larger improvement compared to cranial symptoms (0.07, p < 0.05). Consequently, patients with more pronounced lower limb motor symptoms displayed a greater GPi‐DBS effect (p < 0.01). However, pre‐treatment localization of motor symptoms accounted only for 31% of the Inter‐Patient Variability (IPV) in post‐GPi‐DBS improvement. Amelioration varied also across genetic profiles, with the largest improvement reported for DYT‐TOR1A patients (n = 9, 64.2% in the first year), predicting 36% of IPV. Interestingly, combining motor and genetic profiles predicted 73% of the IPV. Including the clinical profile of the patient (age at onset, disease severity and duration) increased prediction accuracy to 81%. Interpretation Our results suggest that motor and genetic profiles contribute independently to the efficacy of the GPi‐DBS treatment. These results may support a personalized prediction of DBS outcomes in dystonia patients.https://doi.org/10.1002/acn3.70098deep brain stimulationdystoniaoutcome predictorsvariability
spellingShingle Mahboubeh Ahmadipour
Luigi M. Romito
Antonio E. Elia
Nico Golfré Andreasi
Roberto Eleopra
Alberto Mazzoni
Fabiana Colucci
Genetic Profile and Symptom Pattern Explain Variability of Deep Brain Stimulation Effect in Dystonia
Annals of Clinical and Translational Neurology
deep brain stimulation
dystonia
outcome predictors
variability
title Genetic Profile and Symptom Pattern Explain Variability of Deep Brain Stimulation Effect in Dystonia
title_full Genetic Profile and Symptom Pattern Explain Variability of Deep Brain Stimulation Effect in Dystonia
title_fullStr Genetic Profile and Symptom Pattern Explain Variability of Deep Brain Stimulation Effect in Dystonia
title_full_unstemmed Genetic Profile and Symptom Pattern Explain Variability of Deep Brain Stimulation Effect in Dystonia
title_short Genetic Profile and Symptom Pattern Explain Variability of Deep Brain Stimulation Effect in Dystonia
title_sort genetic profile and symptom pattern explain variability of deep brain stimulation effect in dystonia
topic deep brain stimulation
dystonia
outcome predictors
variability
url https://doi.org/10.1002/acn3.70098
work_keys_str_mv AT mahboubehahmadipour geneticprofileandsymptompatternexplainvariabilityofdeepbrainstimulationeffectindystonia
AT luigimromito geneticprofileandsymptompatternexplainvariabilityofdeepbrainstimulationeffectindystonia
AT antonioeelia geneticprofileandsymptompatternexplainvariabilityofdeepbrainstimulationeffectindystonia
AT nicogolfreandreasi geneticprofileandsymptompatternexplainvariabilityofdeepbrainstimulationeffectindystonia
AT robertoeleopra geneticprofileandsymptompatternexplainvariabilityofdeepbrainstimulationeffectindystonia
AT albertomazzoni geneticprofileandsymptompatternexplainvariabilityofdeepbrainstimulationeffectindystonia
AT fabianacolucci geneticprofileandsymptompatternexplainvariabilityofdeepbrainstimulationeffectindystonia